Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in JBIO — Jade Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in JBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$292,037
+$34,810 QoQ
Shares Held
13,143
-28.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 153 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JBIO Over Time

Shares Held

Position Value (USD)

Derivatives in JBIO

reported options exposure · as of Jun 30, 2026
CallValue
$797,698
CallShares
35,900
PutValue
$1,517,626
PutShares
68,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. JBIO ranks #199 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JBIO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $797,698 35,900
2026-06-30 $1,517,626 68,300
2026-06-30 $292,037 13,143
2026-03-31 $257,227 18,308
2026-03-31 $809,280 57,600
2025-12-31 $1,147,992 74,400
2025-09-30 $494,499 57,300
2025-09-30 $152,345 17,653
2025-06-30 $582,417 58,300
2025-06-30 $391,897 39,229
2021-12-31 AVTE 15,769